Cardio Diagnostics Holdings (CDIO) Shares Outstanding (2021 - 2026)

Cardio Diagnostics Holdings has disclosed Shares Outstanding (Entity) across 6 years of filings, most recently posting $3.0 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 70.06% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $3.0 million (up 70.06% YoY), while the FY2025 annual figure was $1.8 million, down 93.21% from the prior year.
• Shares Outstanding (Entity) came in at $3.0 million for Q2 2026 at Cardio Diagnostics Holdings, roughly flat from $3.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $26.9 million in Q4 2024 to a low of $1.7 million in Q1 2025.
• Average Shares Outstanding (Entity) over 5 years is $9.8 million, with a median of $6.5 million recorded in 2022.
• Year-over-year, Shares Outstanding (Entity) surged 310.83% in 2023 and slumped 93.21% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $3.1 million in 2022, then surged by 310.83% to $12.7 million in 2023, then surged by 112.0% to $26.9 million in 2024, then tumbled by 93.21% to $1.8 million in 2025, then jumped by 62.07% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $3.0 million in Q2 2026, $3.0 million in Q1 2026, and $1.8 million in Q4 2025.